Renal-care provider DaVita said it intends to offer $1.45 billion in senior notes and intends to use the proceeds to purchase or redeem its outstanding 6 5/8% senior notes that are due in 2013 and 7 1/4% senior subordinated notes due in 2015. Part of the proceeds will also be used to pay related transaction fees and expenses, according to a news release from Denver-based DaVita.
On Sept. 21, DaVita said its board of directors authorized a comprehensive refinancing of the company's senior secured credit facilities and bond indebtedness.
